Scopolia tangutica Maxim (S. tangutica) extracts have been traditionally used as antispasmodic, sedative, and analgesic agents in Tibet and in the Qinghai province of China. Their active compositions are however poorly understood. We have recently isolated five new hydroxycinnamic acid (HCA) amides along with two known HCA amides, one cinnamic acid amide from these extracts. In this study, we evaluate their abilities to inhibit carbacol-induced activity of M1 muscarinic acetylcholine receptor along with the crude extracts. Chinese hamster ovary cells stably expressing the recombinant human M1 receptor (CHO-M1 cells) were employed to evaluate the anticholinergic potentials. Intracellular Ca 2+ changes were monitored using the FLIPR system.
Introduction
Scopolia tangutica Maxim (S. tangutica) is one of the traditional Chinese medicines used in Tibet and in the Qinghai province of West China. Its extracts have been traditionally used as antispasmodic, sedative, and analgesic agents [1, 2] . Its medicinal importance is associated with high biologically active tropane alkaloids, in particular anisodine and scopolamine [3] [4] [5] . These alkaloids primarily affect the parasympathetic nervous system and act as muscarinic acetylcholine receptor (mAChR) antagonists [6] [7] [8] . mAChR antagonists block the transmission of parasympathetic nerve impulses by acetylcholine and consequently lessen the spasms of smooth muscle [9, 10] . Recently we have isolated five new hydroxycinnamic acid (HCA) amides along with two known HCA amides, one cinnamic acid amide from S. tangutica [11, 12] . The conjugates of HCAs with polyamines have been found in a wide variety of plants and are concentrated in the reproductive organs of many higher plants [13] [14] [15] . The HCA-spermidine conjugates have been proven to be useful for chemotaxonomic purposes in several plant families [16] [17] [18] . The HCA amides have been proposed to have a number of biological activities, including the effects of anti-fungi, antibacteria and anti-tumor [19] [20] [21] , suggesting that HCA amides may have great potential for identifying new molecules for different diseases. It is interesting to note the similarity of the plant derived HCA amides to polyamine conjugates found in the invertebrate venom [22, 23] . Some of these invertebrate toxins have been found as neurotransmitter receptor ligands [24, 25] . In this study, we examined the anticholinergic potential of these HCA amides and compared the anticholinergic properties to the crude extract. The goal of the study is to foster a better understanding of the traditional use of S. tangutica and pursuit of the discovery of novel drugs. mAChRs belong to G protein-coupled receptors (GPCR) family A. They are found in nervous system where they mediate the metabotropic actions of the neurotransmitter acetylcholine, in particular its parasympathetic action. They are major drug targets in human disease therapies. Five subtypes of mAChRs, classified as M1-M5, have been identified [26] . M1, M3 and M5 receptors couple to Gq proteins, which mediate intracellular calcium mobilization upon stimulation. M2 and M4 receptors couple to Gi proteins which inhibit adenylyl cyclase activity [27] . The sequence similarities found among these receptors infer that binding of a ligand to one of them should insure binding to all. In this study we chose to use the M1 receptor as the lead receptor. 
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Plant materials
The roots of S. tangutica were collected from Jiuzhi county (at 100°40′19″ E; 33°16′56″ N), Qinghai province, People's Republic of China. Voucher specimens (QTPMB) were deposited at Qinghai-Tibet Plateau Museum of Biology, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, and were identified by Senior Engineer Lijuan Mei.
Extract preparation and compound purification
The crude extract was prepared as described before [28] . In brief, 95 g S. tangutica was grounded into powder and extracted twice with 1 L ethanol-water (95:5, v/v) at 80°C for 3 h. The crude extracts were obtained by rotary evaporation of the solvent. 1 mL of crude extract was dissolved in 5 mL of methanol. An aliquot of 0.1 mL of crude extract sample was applied to the conditioned SCX-based solid phase extraction column. The isolation and identification of pure compounds from S. tangutica are extensively described by our most recent report [12] . Briefly, S. tangutica were extracted by 95% ethanol. The isolation of pure compounds was achieved by multi-dimensional HPLC. The identity of the isolated compounds was confirmed by spectroscopic and spectrometric methods (1D-and 2D-NMR, LC-MS, optical rotation). The purity of all isolated compounds was ≥98%.
M1 receptor activity measurement
Chinese hamster ovary cells stably expressing the recombinant human M1 receptor (CHO-M1 cells) were kindly provided by Dr. Naoto Hoshi (University of California, Irvine). The M1 receptor inhibitory activity was determined by Fluorometric Imaging Plate Reader (FLIPR). The assay was performed as reported earlier with slight modification [29] . Briefly, the cells were seeded into black wall, clear-bottom 96-well plates at a density of 60,000 cells per well. Twenty-four hours later the medium was removed and replaced with 100 μl of dye loading solution (2 μM Fluo-4 AM dissolved in FLIPR buffer, which consists of pluronic acid in 1 × Hank's buffer supplemented with 20 mM HEPES, pH 7.4) for 1 h at 37°C. The cells were then washed 3 times with FLIPR buffer prior to FLIPR assay. The compounds were dissolved in dimethyl sulphoxide (DMSO) and diluted with FLIPR buffer. For antagonist tests, the compounds were first incubated with the cell for 10 min, before the addition of 50 nM carbacol to induce the activity of M1 receptor. Data were expressed as fluorescence (arbitrary units) versus time.
Data processing
IC 50 values and curve fitting were determined using Graphpad Prism (GraphPad Software, Inc., San Diego, CA). Data from each doseresponse curve were normalized to the carbacol (50 nM) stimulation. At least three independent experiments were performed. Data are presented as means ± standard error of the mean (SEM). (7); one cinnamic acid amide: carboxyscotangamine A (8) and three well-known anticholinergic compounds (9-10): scopolamine (9), atropine (10) and anisodine (11).
Results and discussion
Eleven alkaloids have been isolated from S. tangutica [11, 12] . They include seven HCA amides (1-7): scotanamine A-D (1-4), N 1 ,
-dihydrocaffeoylspermidine (7), one cinnamic acid amide: carboxyscotangamine A (8) and three well-known anticholinergic compounds (9-10): scopolamine (9), atropine (10) and anisodine (11) . Their structures were shown in Fig. 1 .
These alkaloids as well as the S. tangutica crude extract, from where they were isolated, were tested for their abilities at inhibiting the muscarinic M1 receptor. As shown in Fig. 2A , the crude extract was able to dose-dependently inhibit the carbacol-induced calcium mobilization. At a concentration of 2 μg/mL the M1 receptor activation is practically totally inhibited.
Then the purified alkaloids were tested for their abilities to antagonize the M1 receptor. First the well-known anticholinergic compounds scopolamine (9), atropine (10) and anisodine (11) displayed potent inhibitory activity against M1 receptor (Fig. 2B) with IC 50 values of 1.6, 28 and 82 nM, respectively. These values are in agreement with published data [4, 8] . These compounds could serve as positive controls in the assay.
We then accessed whether these seven HCA amides and one cinnamic acid amide have inhibitory effects on M1 receptors. We screened the activities of these eight compounds at a concentration of 10 μM in CHO-M1 cells. As shown in Fig. 2C , compounds 1 and 6 were able to inhibit carbacol induced M1 receptor activities by 35-40% and potent inhibition was noted with compounds 2-5 and 7 at a range of 80-100%.
The concentration-inhibition relationships for compounds 2-5 and 7 were further studied (Fig. 2D) . scotanamine D (4) displayed the best inhibitory activity against M1 receptor with an IC 50 value of 32 nM, followed by scotanamine B (compound 2, 397 nM), N 1 -caffeoyl-N 3 -dihydrocaffeoylspermidine (compound 7, 863 nM), N 10 -di-dihydrocaffeoylspermidine (compound 5, 2.9 μM) and scotanamine C (compound 3, 7.8 μM). To study the selectivity of the response, these compounds were tested in HEK293T cells expressing ORL-1 receptor and displayed no activities (data not shown). Here compared to compound 9-11, compound 1-4 and 8 are newly discovered natural products, therefore our findings provide their first biological assessment. Because the conjugated molecules 2-5 contain caffeic acid and polyamine backbones, we tested whether caffeic acid itself exhibits activity at the M1 receptor. However, caffeic acid did not show any activity against M1 receptor (Fig. 2C) at concentrations up to 10 μM. Regarding the polyamine backbone, we found that the short chain amine conjugates (compounds 1, 6 and 8) are much less active than the longer chain ones (compounds 2-5 and 7). This points at the importance of the polyamine chain in the binding to the M1 receptor. The polyamine backbone has been proposed as a key pharmaceutical skeleton in the binding of different receptors [19] . Methoctramine is the prototype polymethylene tetraamine for antagonism of mAChRs [30] . A more complete analysis of the role of the polyamine chemical structure on biological activity will require a higher number of compounds and remains to be studied.
Conclusions
Our study shows that HCA amides can inhibit the M1 receptor activity as well as the crude S. tangutica extracts. Therefore these HCA Data are mean ± SEM.
amides may participate in the therapeutic action of S. tangutica extracts. Our study revealed that not only anisodine and scopolamine, but also the presence of some of HCA amides are responsible for the anticholinergic effects of this plant medicine. Our findings thus provided additional molecular basis for the traditional use of S. tangutica against spasm. Noteworthy, mAChR antagonists were also among the first drug for Parkinson's disease (PD) and still are widely used today [31, 32] . Thus, these HCA amides described here may also have a therapeutic potential in PD. Further studies will clarify the selectivity of these compounds at different subtypes of mAChRs.
